Feb 24, 2021

Featuring an interview with Dr Erika Hamilton on the following topics:

• Management of ER-positive metastatic breast cancer (0:00)
• Case: A woman in her early 60s with de novo ER-positive metastatic breast cancer develops a rash while receiving a PI3K inhibitor (24:08)
• Case: A woman in her early 60s receives an oral SERD for progressive ER-positive metastatic breast cancer (26:24)
• Tolerability and toxicity of available therapies for ER-positive metastatic breast cancer (28:14)

CME information and select publications